Silodosin Glucuronide D4: a key standard for deuterium-labeled metabolite research

Silodosin Glucuronide D4 is a stable isotope-labeled glucuronide metabolite designed for use in drug metabolism and pharmacokinetic studies. As one of the main metabolites of silodosin, its deuterated form plays a key internal standard role in mass spectrometry analysis, providing excellent accuracy and reproducibility for quantitative analysis. It is an indispensable reference standard to support modern drug development and bioanalysis.

Chemical Information

Chemical name: Silodosin Glucuronide D4

Generic name: Silodosin Glucuronide D4

Chemical formula: C31H36D4F3N3O10

Molecular weight: 675.69 g/mol

Category: Metabolite Glucuronide

Structural features

Silodosin Glucuronide D4 has the following significant structural features:

Specific deuterium labeling: Four hydrogen atoms in the molecule are replaced by its stable isotope deuterium (D). This labeling hardly changes the chemical and physical properties of the original metabolite, but can produce a clear mass shift, making it clearly distinguishable from unlabeled natural metabolites in mass spectrometry detection.

Glucuronide conjugated form: This compound is a covalent conjugate formed by silodosin catalyzed by glucuronosyltransferase metabolism. This conjugation reaction is one of the main ways for many drugs (especially drugs containing hydroxyl or carboxyl groups) to undergo phase II metabolism in the body and enhance water solubility for excretion.

Complete pharmacophore retention: The metabolic connection site is usually far away from the core pharmacologically active group of the drug, so that while retaining some structural characteristics of the parent drug, the formation and elimination process of the glucuronic acid metabolite directly affects the in vivo exposure and half-life of the parent drug.

Main applications and value

The cornerstone of precision bioanalysis

In pharmacokinetic studies, especially when using LC-MS/MS technology for quantitative analysis of biological samples (such as plasma, urine), Silodosin Glucuronide D4 is crucial as an internal standard. It can effectively correct losses during sample pretreatment, matrix effects and fluctuations in instrument response, thereby achieving absolutely accurate quantification of natural Silodosin Glucuronide, ensuring reliable data and meeting the strict requirements of regulatory agencies for bioanalytical methods.

Tools for drug metabolism pathway research

This compound provides a direct reference for clarifying the metabolic fate of silodosin in the body. Through comparative analysis, researchers can clearly track the ratio and rate of conversion of parent drugs into glucuronic acid conjugates, which helps to completely outline the metabolic profile of the drug and evaluate the role of metabolism in drug clearance.

Support regulatory submissions and clinical research

In drug development applications such as IND and NDA, it is a routine requirement to provide detailed pharmacokinetic data on major metabolites. The data obtained using the certified Silodosin Glucuronide D4 as the standard has a high degree of credibility and recognition, and can effectively support the safety and effectiveness evaluation of drugs and accelerate the research and development process.

In vitro metabolism model validation

In in vitro experiments such as liver microsomes, recombinant enzymes or hepatocytes, this deuterated standard can be used to verify the generation of metabolites, assist in the identification of key enzyme subtypes responsible for metabolism (such as UGT enzymes), and assess the potential risk of drug-drug interactions.

Conclusion

Silodosin Glucuronide D4 is more than just a chemical entity, it is a sophisticated bridge between medicinal chemistry, metabolic research and clinical pharmacology. Its value in improving analytical quality, elucidating metabolic mechanisms, and meeting regulatory compliance requirements makes it a critical tool molecule in drug discovery and development laboratories. From preclinical development to clinical monitoring, its application runs through the entire chain of modern innovative drug research and development.

The above information is provided by the editor of KASONS and is for scientific research only.